Navigation Links
Anadys' Setrobuvir Named One of Windhover's Top 10 Most Interesting Infectious Disease Projects to Watch
Date:9/7/2011

leosides.  Setrobuvir has a well-characterized safety database in which more than 350 subjects have received the agent to date.  Anadys was granted U.S. Patent No. 7,939,524, which recognizes the Company's intellectual property rights to the composition of matter and methods of use for setrobuvir and related compounds. Setrobuvir has also received Fast Track Status from the FDA for the treatment of chronic hepatitis C or HCV.

Setrobuvir is currently in Phase IIb testing in combination with pegylated interferon and ribavirin for the treatment of HCV.  The primary endpoint of the study is Sustained Virological Response 24 weeks after patients complete treatment, known as SVR24.  All patients are scheduled to complete their 12 week visit by the end of the third quarter of 2011 and the Company expects to release preliminary 12 week data shortly thereafter.  Antiviral response data through 24 weeks are expected around year-end.  

In the second quarter this year, Anadys announced a cross-company clinical trial agreement with a large, commercial-stage biopharmaceutical company to study setrobuvir in combination with another DAA in healthy volunteers.

About Anadys

Anadys Pharmaceuticals, Inc. is a biopharmaceutical company dedicated to improving patient care by developing novel medicines for the treatment of hepatitis C.  The Company believes hepatitis C represents a large unmet medical need in which meaningful improvements in treatment outcomes may be attainable with the introduction of new medicines.  Anadys is conducting a Phase IIb study of setrobuvir (ANA598), the Company's DAA, added to current standard of care for the treatment of hepatitis C.  The Company is  also developing ANA773, the Company's oral, small-molecule inducer of endogenous interferons that acts via the Toll like receptor 7, or TLR7, pathway in hepatitis C and plans to initiate a Phase IIa study shortly.

S
'/>"/>

SOURCE Anadys Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Anadys Announces Issuance of U.S. Patent Covering Setrobuvir (ANA598)
2. Anadys Pharmaceuticals Reports First Quarter 2011 Financial Results and Highlights
3. Anadys Pharmaceuticals Appoints Barry Labinger to Its Board of Directors
4. Anadys Pharmaceuticals to Present at the Cowen & Company Healthcare Conference
5. Anadys Pharmaceuticals to Report Fourth Quarter and Year-end 2010 Financial Results
6. Anadys Pharmaceuticals to Present at the Bio CEO & Investor Conference
7. Anadys Pharmaceuticals to Present at the J.P. Morgan Healthcare Conference
8. Anadys Pharmaceuticals Initiates Phase IIb Study of ANA598 in HCV Patients
9. Anadys Pharmaceuticals Reports Third Quarter 2010 Financial Results and Highlights
10. Anadys Pharmaceuticals to Report Third Quarter 2010 Financial Results
11. Anadys Pharmaceuticals, Inc. Announces Proposed Public Offering of Common Stock
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/20/2014)... -- Glenmark Pharmaceuticals S.A. (GPSA), a ... (GPL), announces the discovery and initiation of IND ... GBR 1302, a HER2xCD3 bispecific antibody. GBR 1302 ... Research Centre located in La Chaux-de-Fonds, ... Glenmark,s innovative BEAT antibody technology platform which facilitates ...
(Date:8/19/2014)... Aug. 19, 2014  The Alabama Supreme Court, in a ... sue drug makers who mislead doctors into believing that prescription ... case is Weeks v. Wyeth, and the decision came after ... same case last year. Heninger Garrison Davis attorneys Lew ... in the case, Danny Weeks . The ...
(Date:8/19/2014)... 2014 Minimally Invasive Devices Inc. (MID), a ... announced today that Mitsubishi Corporation has formally agreed to ... in Japan . MID anticipates that ... Japan in the second half of 2015. ... for Karl Storz GMBH & Co. (endoscopic instruments and ...
Breaking Medicine Technology:Glenmark Enters Oncology With the Discovery and Initiation of IND Enabling Studies of an Innovative Bispecific Antibody 2Glenmark Enters Oncology With the Discovery and Initiation of IND Enabling Studies of an Innovative Bispecific Antibody 3Heninger Garrison Davis Clients To Get Their Day in Court Against Brand Drug Companies 2Heninger Garrison Davis Clients To Get Their Day in Court Against Brand Drug Companies 3Heninger Garrison Davis Clients To Get Their Day in Court Against Brand Drug Companies 4Minimally Invasive Devices and Mitsubishi Medical Japan Forge Exclusive Distribution Agreement 2
... DATATRAK International, Inc.(OTCQX: DATA), a technology and services ... trials industry, today announced the signing of two new ... award includes a multi-site, five-year study and demonstrates a ... , "We are pleased that our partnership ...
... CHEYENNE, Wyo., Aug. 24 The Wyoming Department of Health ... program, a component of its innovative Total Health Record initiative. ... community and the Wyoming EqualityCare (EC) Healthy Together program, as ... , , (Logo: http://www.newscom.com/cgi-bin/prnh/2008 ...
Cached Medicine Technology:Research-Based Biopharmaceutical Company Awards Trials to DATATRAK 2Research-Based Biopharmaceutical Company Awards Trials to DATATRAK 3Wyoming Department of Health's Pay-for-Participation Program Reports Positive Clinical Outcomes 2Wyoming Department of Health's Pay-for-Participation Program Reports Positive Clinical Outcomes 3
(Date:8/20/2014)... Ticket Down is a reliable source ... at the Sun Life Stadium in early September. , Two ... Brazil and Colombia meet at Sun Life Stadium in Miami Gardens, ... in the world and will be a rematch of their thriller ... kick-off on Sept. 5 and will feature some of the best ...
(Date:8/20/2014)... August 20, 2014 The finalists are ... leading health-marketing industry trade magazine, will honor the pharmaceutical ... Awards are given to outstanding companies, marketers and brand ... , “We are proud to announce that we ... entries with double the number of submissions we received ...
(Date:8/20/2014)... 2014 Botanica Day Spa ... Utilizing the new and popular stem cell line ... lines and wrinkles and naturally repairs the skin. ... the new service by offering clients a complimentary ... cell facial. , Pevonia® continues to be a ...
(Date:8/20/2014)... Brain Tumour Research has been chosen by Plymouth University ... was launched in April 2009 to raise awareness of, ... improve outcomes for brain tumour patients. , A range ... raise funds for the charity, and members of staff ... be encouraged to donate, fundraise and volunteer. The involvement ...
(Date:8/20/2014)... If old age is a disease then this ... extensive research on HGH and stem cells technology, the L.A. ... the art of rubbing off decades from your face and ... their revolutionary anti-aging hormone therapy and regenerative medicine. , ... youth, the MD of MetroMD, Dr Alex Martin said this ...
Breaking Medicine News(10 mins):Health News:Brazil vs. Colombia Tickets in Miami, FL: Ticket Down Slashes Colombia vs. Brazil Tickets at Sun Life Stadium in Miami for Sept. 5th Match 2Health News:Brazil vs. Colombia Tickets in Miami, FL: Ticket Down Slashes Colombia vs. Brazil Tickets at Sun Life Stadium in Miami for Sept. 5th Match 3Health News:PM360 Announces 2014 Trailblazer Award Finalists 2Health News:PM360 Announces 2014 Trailblazer Award Finalists 3Health News:PM360 Announces 2014 Trailblazer Award Finalists 4Health News:PM360 Announces 2014 Trailblazer Award Finalists 5Health News:PM360 Announces 2014 Trailblazer Award Finalists 6Health News:PM360 Announces 2014 Trailblazer Award Finalists 7Health News:PM360 Announces 2014 Trailblazer Award Finalists 8Health News:New Stem Cell Facial Unveiled at Botanica Day Spa 2Health News:New Stem Cell Facial Unveiled at Botanica Day Spa 3Health News:Plymouth University chooses Brain Tumour Research as official charity 2Health News:MetroMD Offers Revolutionary Anti-aging Hormone Therapy in Hollywood Area 2
... BUFFALO, N.Y. -- The University at Buffalo announced today a ... and family to establish the Jacobs Institute, which will support ... of heart and vascular diseases. , ... was made in honor of Lawrence D. Jacobs, M.D., a ...
... 13 Market competition is,mounting to win ... most highly,qualified clinical investigators. Companies that develop ... their studies win an advantage in,bringing their ... white paper "Recruiting and Retaining,High-Quality Clinical Investigators" ...
... for recent disasters, WASHINGTON, June 13 The ... with relief efforts for,the victims of flooding and tornadoes ... West Virginia, the Red Cross is present,with vast amounts ... of,thousands of meals., Already, more than 1,400 Red ...
... Long and costly product,development cycles make it essential ... to the development of compounds with,the greatest potential ... and earlier into the new product process in ... development cycle,time, focus resources for greatest impact and ...
... lead to diagnostic urine test for 10% of men with ... traits of an aggressive type of prostate cancer that occurs ... been identified in hopes of finding a way to diagnose ... the Michigan Center for Translational Pathology at the University of ...
... June 2008: The TRAF1/C5 locus on chromosome 9 has ... diseases including type 1 diabetes and systemic lupus erythematosus ... 2008, the Annual Congress of the European League Against ... Factor-receptor associated factor 1) and C5 (complement component 5) ...
Cached Medicine News:Health News:$10 million gift will retain and recruit world-class researchers to University at Buffalo 2Health News:$10 million gift will retain and recruit world-class researchers to University at Buffalo 3Health News:$10 million gift will retain and recruit world-class researchers to University at Buffalo 4Health News:American Red Cross Issues Appeal for Disaster Relief Fund 2Health News:Bio-Pharma Launch Value Maximized Through New Product Commercialization Excellence 2Health News:Researchers ID Traits of Aggressive Prostate Cancer 2Health News:Specific location of the TRAF1/C5 gene associated with multiple autoimmune diseases 2
... Ergonomic Design for Unparalleled Comfort Pick ... Notice the balance. Notice the trigger and ejector ... Thats because our pipettors are ergonomically designed to ... hours of pipetting. Productivity In The Palm ...
... Design for Unparalleled Comfort Pick one of ... balance. Notice the trigger and ejector positionsright where ... our pipettors are ergonomically designed to help avoid ... pipetting. Productivity In The Palm Of Your ...
... The total ergonomic solution and best value ... feather touch action and ultra lightweight design ... tip ejection with long, lever tip ejector ... , Accepts universal tips or for greater ...
... Finnpipette BioControl multichannel has ... as the single channel ... fits all seven multichannel ... tip cone modules. Both ...
Medicine Products: